102 results
Page 4 of 6
10-Q
EX-10.7
wl3b0vltll l5
20 Sep 21
Quarterly report
4:17pm
10-Q
EX-10.5
l5qadhhls9h
20 Sep 21
Quarterly report
4:17pm
10-Q
8euo e0fg9zf43afo5qq
20 Sep 21
Quarterly report
4:17pm
10-Q
EX-10.6
fnh3nx0e
20 Sep 21
Quarterly report
4:17pm
8-K
EX-99.1
rd3icc2lsh354t99nutq
20 Sep 21
Adagio Therapeutics Provides COVID-19 Antibody Program Updates as well as Business
4:05pm
8-K
EX-99.1
57q0 aa47i5kk
10 Sep 21
Adagio Therapeutics Announces Expansion of Patient Population in Global Phase 2/3 Clinical Trial of ADG20 for the Prevention of COVID-19
7:55am
S-8
6vak1yo4gi9tkg
23 Aug 21
Registration of securities for employees
4:35pm
S-8
EX-23.1
i3nlv8nz38s 9d4tg7
23 Aug 21
Registration of securities for employees
4:35pm
8-K
EX-3.2
qb1t0gokawuiiwkgps
10 Aug 21
Amendments to Articles of Incorporation or Bylaws
5:26pm
424B4
o28z9h6
6 Aug 21
Prospectus supplement with pricing info
4:54pm
S-1MEF
5qp7w3v vy
5 Aug 21
Registration of additional securities for an S-1
9:20pm
S-1MEF
EX-23.1
gab28y
5 Aug 21
Registration of additional securities for an S-1
9:20pm
S-1/A
EX-3.5
wwure2suixh1i09
2 Aug 21
IPO registration (amended)
6:20am
S-1/A
EX-23.1
ldch mvh4
2 Aug 21
IPO registration (amended)
6:20am
S-1/A
EX-10.4
m507svq
2 Aug 21
IPO registration (amended)
6:20am